Articles related to CONTRACEPTION/PREGNANCY

Physicians should be aware that sexual dysfunction encompasses a broad range of factors, including psychological and physical conditions, and is not solely a hormonal issue. Understanding this complexity is key in patient treatment.

Zurzuvae represents a novel approach in postpartum depression therapy, with clinical trials revealing substantial symptom reduction within the initial treatment period. This advancement offers a new horizon in PPD management for healthcare professionals.

Peripartum cardiomyopathy presents a unique challenge in maternal health, with its late pregnancy symptoms often leading to delayed diagnosis. Understanding its hormonal and genetic underpinnings is vital for effective management.

A Maryland family was awarded almost $34 million after an unnecessary emergency C-section led to brain damage in their infant. This case serves as a stark reminder of the potential consequences of medical decisions and the importance of effective communication within healthcare teams.

The recent study underscores the readiness of pharmacists to dispense mifepristone following the FDA’s rule change. With basic training, nearly all participants expressed confidence in their ability to dispense this medication, highlighting your adaptability and resourcefulness.

ACIP’s endorsement of Abrysvo offers a new preventive measure against RSV in infants, urging healthcare providers to discuss this option with expectant parents.